default author photo

Mark Pomerantz

Dana-Farber Cancer Institute - Lank Center for Genitourinary Oncology

United States

SCHOLARLY PAPERS

2

DOWNLOADS

147

TOTAL CITATIONS

1

Scholarly Papers (2)

1.

High Plasma IL-8 and PD-L1 are Associated With Reduced Overall Survival in Metastatic Castration-Resistant Prostate Cancer Patients (mCRPC)

Number of pages: 27 Posted: 18 Nov 2020
Pennsylvania State University - Penn State Hershey Medical Center, Dana-Farber Cancer Institute - Lank Center for Genitourinary Oncology, Pennsylvania State University - Penn State Hershey Medical Center, Harvard University - Lank Center for Genitourinary Oncology, Harvard University - Lank Center for Genitourinary Oncology, Harvard University - Lank Center for Genitourinary Oncology, Harvard University - Lank Center for Genitourinary Oncology, Pennsylvania State University - Penn State Hershey Medical Center, Pennsylvania State University - Penn State Hershey Medical Center, Pennsylvania State University - Penn State Hershey Medical Center, Pennsylvania State University - Penn State Hershey Medical Center, Pennsylvania State University - Penn State Hershey Medical Center, Pennsylvania State University - Penn State Hershey Medical Center, Pennsylvania State University - Penn State Hershey Medical Center, Pennsylvania State University - Penn State Hershey Medical Center, Pennsylvania State University - Penn State Hershey Medical Center, Pennsylvania State University - Penn State Hershey Medical Center, Pennsylvania State University - Penn State Hershey Medical Center, ProteinSimple and Pennsylvania State University - Penn State Hershey Medical Center
Downloads 99 (699,467)

Abstract:

Loading...

plasma IL-8 & PD-L1, overall survival, metastatic prostate cancer

2.

Ethnicity-Specific Variation in the Germline Landscape of Renal Cell Carcinoma

Number of pages: 18 Posted: 15 Oct 2020
Dana-Farber Cancer Institute - Lank Center for Genitourinary Oncology, Harvard University - Lank Center for Genitourinary Oncology, Harvard University - Lank Center for Genitourinary Oncology, Harvard University - Division of Population Sciences, Harvard Medical School - Division of Pulmonary and Critical Care Medicine and Genetics, Dana-Farber Cancer Institute - Lank Center for Genitourinary Oncology, Invitae Corporation, InVitae Corporation, Invitae Corporation, InVitae Corporation, InVitae Corporation, Harvard University - Department of Medicine, Harvard University - Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute - Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute - Division of Population Sciences, Harvard University - Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute - Division of Population Sciences, Harvard University - Division of Population Sciences and Harvard University - Lank Center for Genitourinary Oncology
Downloads 48 (1,086,013)
Citation 1

Abstract:

Loading...

Renal cell carcinoma, kidney cancer, germline variants, DNA damage repair, clinical genetics